Kenvue Inc. logo

Kenvue Inc. (J4D)

Market Open
XETRA XETRA
- Market Cap
21.62 P/E Ratio
0.83% Div Yield
- Volume
1.14 Eps
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0
Want to track J4D and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

J4D pays dividends to its shareholders, with the most recent payment made on May 27, 2026. The next estimated payment will be in In 2 months on Aug 27, 2026 for a total of €0.2075.
The last earnings report, released on May 14, 2026, missed the consensus estimates by -0.2633%. On average, the company has fell short of earnings expectations by -0.1911%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on NYSE (USD).

J4D Chart

Best Consumer Dividend Stocks to Buy Now: HAS, KVUE, MOV

Best Consumer Dividend Stocks to Buy Now: HAS, KVUE, MOV

Here are three top-rated consumer dividend stocks that have yields above 3% and have made their way onto the coveted Zacks Rank #1 (Strong Buy) list.

Zacks | 1 week ago
KVUE or LRLCY: Which Is the Better Value Stock Right Now?

KVUE or LRLCY: Which Is the Better Value Stock Right Now?

Investors with an interest in Consumer Products - Staples stocks have likely encountered both Kenvue (KVUE) and L'Oreal SA (LRLCY). But which of these two stocks is more attractive to value investors?

Zacks | 2 weeks ago
Kimberly-Clark positioned for long-term value creation following Kenvue deal, says Bank of America

Kimberly-Clark positioned for long-term value creation following Kenvue deal, says Bank of America

Kimberly-Clark Corp (NYSE:KMB, XETRA:KMY) has earned a repeat ‘Buy' rating and $120 price objective from Bank of America analysts, who believe that the company's acquisition of Kenvue assets could create long-term value despite near-term integration challenges. The analysts said the deal appears opportunistic, noting the acquisition multiple of about 14 times Kenvue's last-twelve-month adjusted EBITDA and a purchase price of $21.01 per share, roughly in line with Kenvue's market value before Tylenol-related headlines weighed on the stock in September 2025.

Proactiveinvestors | 1 month ago

Kenvue Inc. (J4D) FAQ

What is the stock price today?

The current price is €0.00.

On which exchange is it traded?

Kenvue Inc. is listed on XETRA.

What is its stock symbol?

The ticker symbol is J4D.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.83%.

What is its market cap?

As of today, no market cap data is available.

Has Kenvue Inc. ever had a stock split?

No, there has never been a stock split.

Kenvue Inc. Profile

Household Products Industry
Consumer Staples Sector
Kirk L. Perry CEO
XETRA Exchange
US49177J1025 ISIN
US Country
22,000 Employees
13 May 2026 Last Dividend
- Last Split
4 May 2023 IPO Date

Overview

Kenvue Inc. is a global consumer health firm that offers a wide range of healthcare products through its diverse operational segments: Self Care, Skin Health and Beauty, and Essential Health. Founded in 2022 and headquartered in Skillman, New Jersey, Kenvue Inc. delivers a comprehensive portfolio of products designed to improve the wellness and health of consumers around the world. By leveraging well-known brands across its segments, Kenvue provides solutions for everyday health concerns, from pain relief and cold prevention to skincare and baby care.

Products and Services

  • Self Care: This segment encompasses products for cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and more. Notable brands include Tylenol for pain relief, Motrin for inflammation, Benadryl for allergies, Nicorette for smoking cessation, Zarbee's and ORSLTM for general wellness, Rhinocort for nasal congestion, Calpol for children's fever and pain, and Zyrtec for 24-hour allergy relief.
  • Skin Health and Beauty: Dedicated to maintaining skin health and enhancing beauty, this segment offers products for face and body care, hair care, sun protection, and more. It includes Neutrogena for skincare and acne treatment, Aveeno for moisturizers with natural ingredients, Dr.Ci:Labo for innovative skin solutions, Le Petit Marseillais for shower gels and soaps with enchanting fragrances, Lubriderm for daily moisture, Rogaine for hair regrowth, and OGX for salon-inspired hair care.
  • Essential Health: Focusing on essential healthcare needs, this segment provides oral care, baby care, women's health, wound care, among other products. It features Listerine for oral health, Johnson's products for baby care, Band-Aid for wound protection, Stayfree pads, o.b. tampons, and Carefree liners for feminine hygiene, as well as Desitin Diaper Rash cream to soothe and protect infants.

Contact Information

Address: 1 Kenvue Way
Phone: 908 874 1200